The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The administration of single oral doses of delta‐9‐tetrahydrocannabinol (THC) to patients with cancer pain demonstrated a mild analgesic effect. At a dose of 20 mg, however, THC induced side effects that would prohibit its therapeutic use including somnolence, dizziness, ataxia, and blurred vision. Alarming adverse reactions were also observed at this dose. THC, 10 mg, was well tolerated and, despite its sedative effect, may have analgesic potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Keele, K. D. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91787-5 · Cited by 241
Ames, F. (1958) · Journal of Mental Science · doi:10.1192/bjp.104.437.972 · Cited by 184
Snyder, S. H. (1971) · Medical Entomology and Zoology · Cited by 30
Cited by
Items 301–376 of 376
The Endocannabinoid System in the Vervet Monkey Retina
Bouskila, J., Palmour, R. M., Bouchard, J., & Ptito, M. (2018) · InTech eBooks · doi:10.5772/intechopen.71830 · Cited by 3
Medical marijuana in cancer: harmful or harm reduction?
Thielmann, A., & Daeninck, P. J. (2013) · Clinical Practice · doi:10.2217/cpr.13.15 · Cited by 4
Study of the gastric acid anti-secretory activity of Cannabis sativa in an animal model.
Castillo, G. G., Pachajoa, H., Villota, S. E., Zurita, E., Palacios, M., & Gutiérrez, Ó. (2006) · Colombia medica · doi:10.25100/cm.v37i4.454 · Cited by 3
Is THC an Effective Antiemetic for Cancer Patients? Opinion 1
Frytak, S. (1980) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.30.5.278 · Cited by 3
Behavioral Pharmacology of Cannabinoids
de Wit, H., Kirk, J. M., & Justice, A. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2913-9_9 · Cited by 3
Cannabis and Cannabinoids (PDQ
Integrative, P. (2011) · Cited by 2
Long-Term Administration of Cannabis sativa on Locomotor and Exploratory Behavior in Mice
Okon, V. E., Obembe, A. O., Nna, V. U., & Osim, E. E. (2014) · Research in neuroscience · Cited by 5
Review of Human Studies on Medical Use of Marijuana
Gieringer, D. H., & Norml, C. (1996) · Cited by 3
Cannabis : A Prehistoric Remedy for the Deficits of Existing and Emerging Anticancer Therapies
Nasir, B., Fatima, H., Ahmed, M., Phull, A. R., & Ihsan-ul-Haq (2017) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2017.00012 · Cited by 2
Wirksamkeit, Verträglichkeit und Sicherheit von medizinischem Cannabis
Hoch, E., Schneider, M., von Keller, R., Bonnet, U., Falkai, P., Hasan, A., Häuser, W., Hinz, B., Jakob, L., Kabisch, J., et al. (2018) · Springer eBooks · doi:10.1007/978-3-662-57291-7_4 · Cited by 2
Ferjan, I., Kržan, M., Lipnik‐Štangelj, M., Žiberna, L., Stanovnik, L., & Černe, K. (2015) · Slovenian Medical Journal · doi:10.6016/zdravvestn.1360 · Cited by 3
Archer, J., & Lopata, A. (1979) · The Personnel and Guidance Journal · doi:10.1002/j.2164-4918.1979.tb05156.x · Cited by 2
Some physical properties of novel Cannabis suppositories formulated with theobroma oil
Obonga, W. O., Ogechukwu, O. E., Nnadi, C. O., Osadebe, P. O., Amaechi, A. A., & Onunkwo, G. C. (2014) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp2014.4051 · Cited by 1
“…post-operative and intractable pain, as well as stimulating appetite and antispasmodic (Russo, 2011; Ben, 2006; Hazekamp and Grotenhermen, 2010; Noyes et al., 1975; Wade et al., 2003; Grant, 2001; Tomida et al., 2006; Formukong et al., 1988; Obonga, 2006; Regelson et al., 1976; Di Tomaso et…”
BackgroundKoob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50044-8 · Cited by 1
&NA; (2008) · Survey of Anesthesiology · doi:10.1097/01.sa.0000318630.74834.6b · Cited by 1
O uso do cannabidiol no tratamento e manejo da dor
Maccori, G. F., Nascente, I. M., Ceigol, P. A. B., da Silva, E. F., Bernardes, C. O., Lorenz, V. H. D., de Carvalho, T. N. N., Santos, A. C. A. N., Hanna, L. M., de Sá, J. V. F., et al. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n2-255 · Cited by 1
Portenoy, R. K. (1996) · Elsevier eBooks · doi:10.1016/b978-012426910-1/50010-8 · Cited by 1
Zalman, D., & Bar-Sela, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00104-6 · Cited by 2
Cannabinoids for the treatment of cancer-related pain: a systematic review
Tallant, J. (2020) · Cancer Nursing Practice · doi:10.7748/cnp.2020.e1669 · Cited by 2
Chung, M. J., Benkli, B., Hirani, S., & Le-Short, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_26 · Cited by 1
Beaulieu, P., & Ware, M. A. (2004) · Drogues santé et société · doi:10.7202/008537ar · Cited by 2
Cannabinoid mediated diuresis in mice
Chopda, G. R. (2013) · Digital Repository Service (Northeastern University) · doi:10.17760/d20196364
Cannabinoide in der Palliativmedizin
Kress, H. G., & Kraft, B. (2006) · Springer eBooks · doi:10.1007/3-211-32188-8_13 · Cited by 1
Shall we be using cannabis for pain control?
Kapur, D. (2003) · Progress in Palliative Care · doi:10.1179/096992603322731134 · Cited by 1
“The earliest appropriately randomised and blinded trials which were conducted by Noyes and colleagues (3,4) were able to show a modest analgesia provided by delta-9-tetrahydrocannabinol (D9THC).”
BackgroundCannabinoids in the Treatment of Pain
Dubois, M. Y., Nahas, G. G., & Sutin, K. M. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_56 · Cited by 1
Cannabinoid targets for pain therapeutics
Huang, S. M., & Walker, J. M. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_8 · Cited by 3
Marijuana: Pharmacology and Interaction with the Endocannabinoid System
Wiley, J. L., & Martin, B. R. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn040
Toxicology of Substances of Abuse
Vo, E., & Crisce, D. D. (2012) · Wiley eBooks · doi:10.1002/9781118340851.ch10
Endocannabinoidi e Fitocannabinoidi nel Cancro
Ligresti, A. (2006) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/738
Brust, J. C. M. (2007) · Elsevier eBooks · doi:10.1016/b978-2-84299-712-0.50007-3
Hollister, L. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_5
Mathre, M. L. (2001) · The Drug and Alcohol Professional · doi:10.1108/17459265200100011
Cannabinoid modulation of nociception and nociceptor activity during inflammation.
Potenzieri, C. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)
Design and synthesis of novel cannabinergic analogs with controlled detoxification
Sharma, R. (2011) · Digital Repository Service (Northeastern University) · doi:10.17760/d20002953 · Cited by 1
Cannabis in der Supportivtherapie
Göpfert, M., & Hübner, J. (2012) · Info Onkologie · doi:10.1007/s15004-012-0205-4
Gupta, K. (2016) · TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH · doi:10.21522/tijcr.2014.03.01.art011
“to this intervention there was marked improvement in appetite and pain [40-54].”
BackgroundInfluentialBeaulieu, P., Boulanger, A., Desroches, J., & Clark, A. J. (2016)
Case Report #10—Euthanasia (Assisted Suicide) or Palliative Sedation
Plourde, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-815966-8.00010-2
Pino, C. A. (2019) · Cancer · doi:10.1002/9781119645214.ch26
Rice, A. S. C. (2007) · Elsevier eBooks · doi:10.1016/b978-84-8174-949-6.50034-4
Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50011-8
Cannabis in Palliative Medicine
Saint-Preux, F., Arora, A., Moriyama, D., Kim, E., & Kim, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-45968-0_13
Framing the use of cannabis as a medicine in New Zealand: Regulatory, Clinician and Patient contexts
Oldfield, K. (2021) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.14633439.v1 · Cited by 1
Pertwee, R. G. (2003) · CRC Press eBooks · doi:10.1201/9780203911259.ch56
Geschwinde, T. (2018) · Springer eBooks · doi:10.1007/978-3-662-56275-8_1
Geschwinde, T. (2012) · Springer eBooks · doi:10.1007/978-3-642-30163-6_1
Rice, A. S. C. (2006) · Elsevier eBooks · doi:10.1016/b0-443-07287-6/50039-4 · Cited by 4
(2007) · Springer eBooks · doi:10.1007/978-3-540-72045-4_2
Cannabinoide in der Palliativmedizin
Kress, H. G., & Kraft, B. (2012) · Springer eBooks · doi:10.1007/978-3-211-88877-3_13
Cesselin, F. (2001) · Douleur et Analgésie · doi:10.1007/bf03012689
Cannabis thérapeutique : prise en charge de la douleur et autres symptômes du cancer
Boden, A. (2022) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/j.douler.2022.05.006 · Cited by 1
Use of Medical Cannabis in Palliative & Supportive Care
Capos, I. P. (2022) · Journal of Internal Medicine Research & Reports · doi:10.47363/jimrr/2022(1)112
"Use of Medical Cannabis in Palliative & Supportive Care"
Capos, I. P. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.45.007210
Cannabinoide in der Palliativmedizin
Kress, H. G., & Kraft, B. (2023) · Springer eBooks · doi:10.1007/978-3-662-64329-7_15
O uso de canabinóides em pacientes com dor oncológica: uma revisão integrativa de literatura
Madureira, L. G., Avelino, T. F., Baldini, N. L. F., Lima, S. S. D., Rodrigues, M. L. P., Oliveira, V. E. S. D., Filho, E. A. N., & Miziara, A. C. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n3-413
O uso de canabinóides como adjuvante no tratamento da dor oncológica: uma revisão sistemática
Gregório, W. W., Muniz, A. C. W. G., & Nascimento, B. V. D. S. (2023) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.16n.9-136
Riaz, T., & Akram, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95927-8.00021-9 · Cited by 1
New Targets for Cancer Pain Relief
Antoniazzi, C. T. D. D., Kudsi, S. Q., da Silva, B., Pereira, L. G., Frare, J. M., & Trevisan, G. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_342
Hübner, J. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-15076-0.00002-8
Rock, E. M., & Parker, L. A. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_554
Cannabis and Cannabinoids for Treating Pain: What Are the Data?
Khalsa, J. H., Potenza, M. N., Bunt, G. C., & DuPont, R. L. (2025) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001537
Parasympathetic and Sympathetic Nervous System Dysfunction and Monitoring
DePace, N. L., Soloway, S., Yayac, M. F., & Colombo, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-88769-7_13
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517185
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517173
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517164
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517176
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517179
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517167
Pain Management of Spine Tumors
Siddarthan, I. J., & Gulati, A. (2025) · Springer eBooks · doi:10.1007/978-3-032-07519-2_14
Association Between Cannabis Use and Tinnitus: A Multi‐Center Propensity‐Score‐Matched Cohort Study
Ayo‐Ajibola, O., Jung, T., Gonzalves, D. A., Park, A. C., Lin, M. E., Kim, I., Cooper, Z. D., & Choi, J. S. (2026) · OTO Open · doi:10.1002/oto2.70251
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-816791-5.00001-7
Younger, D. S. (2026) · Neurologic Clinics · doi:10.1016/j.ncl.2026.08.019
Analgesic Properties of THC and Its Synthetic Derivatives
Lichtman, A. H., & Martin, B. R. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_50
Metadata
- Authors
- Noyes, R., Brunk, S. F., Avery, D. H., & Canter, A.
- Affiliations
- University of Iowa (US)
- ORCID
- Avery, David H.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1975-07
- Volume
- 18
- Issue
- 1
- Pages
- 84-89
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2415446085
- Cited by
- 378
- References
- 4
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 15 · 2023: 14 · 2022: 20 · 2021: 10 · 2020: 16 · 2019: 10 · 2018: 18 · 2017: 11 · 2016: 15 · 2015: 7 · 2014: 11 · 2013: 8 · 2012: 11
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- delta-9-tetrahydrocannabinol, codeine, analgesia, cancer pain, oral administration, adverse drug reactions, sedation, dose-response relationship, drug tolerance
- MeSH terms
- Analgesics, Aspirin, Cannabis, Clinical Trials as Topic, Codeine, Drug Therapy, Combination, Female, Humans, Male, Phytotherapy, Middle Aged, Neoplasms, Pain, Palliative Care, Placebos, Dextropropoxyphene, Dronabinol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.